Target intelligence / Profile preview

Ankyrin repeat and SOCS box protein 13 (ASB13)

Target
ASB13
Molecular classification
E3 ubiquitin ligase[4][6][7], Ankyrin repeat domain-containing protein[1][2][3], SOCS box protein[1][2][3]
01

Overview

Ankyrin repeat and SOCS box protein 13 (ASB13) is a member of the ankyrin repeat and SOCS box (ASB) family of proteins, characterized by the presence of ankyrin repeat domains and a C-terminal SOCS box[1][2][3]. The SOCS box links substrate proteins to an Elongin-Cullin-SOCS-box (ECS) E3 ubiquitin ligase complex, facilitating their ubiquitination and subsequent degradation by the proteasome[3][6][7]. ASB13 is implicated in regulating Notch signaling and mitochondrial function, and is involved in the control of compartment size in tissues such as brain and muscle[4]. Dysregulation or mutation of ASB13 has been associated with several disease areas, most notably hematologic cancers and potentially neuropsychiatric conditions[3].

Other names
ASB13ankyrin repeat and SOCS box containing 13[2][3]
02

Mechanism of action

Promotion of ubiquitination and proteasomal degradation of substrate proteins via its role as part of an Elongin-Cullin-SOCS-box (ECS) complex[3][6][7]

03

Biological functions

Ubiquitination of target proteins[4][6][7]Regulation of protein degradation (proteasome-dependent)[3][6][7]Regulation of Notch signaling[4]Modulation of compartment size (brain and muscle)[4]
04

Disease associations

Cancer (including hematologic cancers)[3]Possibly in neurodevelopmental or neuropsychiatric disorders (evidence for obsessive-compulsive personality disorder)[3]Other (potential in organ size regulation; mechanism under investigation)[4]

Beyond the preview

Go deeper on Ankyrin repeat and SOCS box protein 13 (ASB13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat and SOCS box protein 13 (ASB13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call